← Back
$EIKN All transactions

Eikon Therapeutics, Inc.

C

$ Value

$0

Shares

408,725

Price

$0

Filed

Feb 6

Insider

Name

Foresite Capital Management IV, LLC

Title

CIK

0001704132

Roles

10% Owner

Transaction Details

Transaction Date

2026-02-04

Code

C

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

408,725

Footnotes

Immediately prior to the closing of the Issuer's initial public offering of its Common Stock, each share of Series A Preferred Stock, Series A-1 Preferred Stock, Series B-1 Preferred Stock, Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into approximately 0.1340878 shares of Common Stock and has no expiration date. | The shares are held of record by Foresite Capital Fund IV, L.P. ("Fund IV"). Foresite Capital Management IV, LLC ("FCM IV") is the general partner of Fund IV and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum ("Tananbaum"), the managing member of FCM IV, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and, other than Fund IV, disclaims beneficial ownership of the shares held by Fund IV, except to the extent of such person's pecuniary interest in such securities. | The shares are held of record by Foresite Capital Fund V, L.P. ("Fund V"). Foresite Capital Management V, LLC ("FCM V") is the general partner of Fund V and may be deemed to have sole voting and dispositive power over such shares. James B. Tananbaum ("Tananbaum"), the managing member of FCM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and, other than Fund V, disclaims beneficial ownership of the shares held by Fund V, except to the extent of such person's pecuniary interest in such securities. | The shares are held of record by Foresite Capital Opportunity Fund V, L.P. ("Opportunity Fund V"). Foresite Capital Opportunity Management V, LLC ("FCOM V") is the general partner of Opportunity Fund V and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FCOM V, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Exchange Act, and, other than Opportunity Fund V, disclaims beneficial ownership of the shares held by Opportunity Fund V, except to the extent of such person's pecuniary interest in such securities. | The shares are held of record by Foresite Capital VI-A, LLC ("Fund VI-A"). Foresite Capital VI-A Management, LLC ("FC VI-A Management") is the general partner of Fund VI-A and may be deemed to have sole voting and dispositive power over such shares. Tananbaum, the managing member of FC VI-A Management, may be deemed to have sole voting and dispositive power over such shares. Each of the Reporting Persons disclaims the existence of a "group", as defined in Rule 13d-5 of the Exchange Act, and, other than Fund VI-A, disclaims beneficial ownership of the shares held by Fund VI-A, except to the extent of such person's pecuniary interest in such securities.

Filing Info

Accession No.

0001104659-26-011662

Form Type

4

Issuer CIK

0001861123

Foresite Capital Management IV, LLC's History

Date Ticker Type Value
2026-02-04 EIKN C $0
2026-02-04 EIKN C $0
2026-02-04 EIKN C $0
2026-02-04 EIKN C $0
2026-02-04 EIKN C $0
2026-02-04 EIKN C $0
2026-02-04 EIKN C $0
2026-02-04 EIKN C $0
2026-02-04 EIKN C $0
2026-02-04 EIKN C $0

Other Insiders at EIKN (90d)

Insider Bought Sold Last
Column Group IV GP, LP $38.1M 2026-02-06
Lux Venture Partners V, LLC $5.0M 2026-02-06
Wolfe Josh $5.0M 2026-02-06
FRAZIER KENNETH C $2.0M 2026-03-02
Foresite Capital Management IV, LLC $1000K 2026-02-04
PERLMUTTER ROGER M
See remarks
2026-03-02
Baynes Roy D.
Chief Medical Officer
2026-03-02
Huffines Robert Luther 2026-03-02
Klobuchar Michael A
Chief Operating Officer
2026-03-02
Thorner Benjamin Bruno
See Remarks
2026-03-02
Bowie Alfred Lloyd Jr.
Chief Financial Officer
2026-03-02